China SXT Pharmaceuticals Inc (SXTC)
0.642
-0.02
(-2.37%)
USD |
NASDAQ |
Sep 27, 16:00
0.7009
+0.06
(+9.17%)
After-Hours: 20:00
China SXT Pharmaceuticals EPS Diluted (Annual): -3.572 for March 31, 2024
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
Date | Value |
---|---|
March 31, 2024 | -3.572 |
March 31, 2023 | -22.23 |
March 31, 2022 | -137.92 |
March 31, 2021 | -95.48 |
Date | Value |
---|---|
March 31, 2020 | -832.05 |
March 31, 2019 | 149.50 |
March 31, 2018 | 100.01 |
March 31, 2017 | 99.80 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-832.05
Minimum
2020
-3.572
Maximum
2024
-218.25
Average
-95.48
Median
2021
EPS Diluted (Annual) Benchmarks
Sinovac Biotech Ltd | -1.06 |
CASI Pharmaceuticals Inc | -2.02 |
Zai Lab Ltd | -3.50 |
Adagene Inc | -0.4375 |
LakeShore Biopharma Co Ltd | -0.5665 |